Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03936322 · ClinicalTrials.gov registry record · NA
Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study
A NA study, sponsored by Rodrigo Ruano.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03936322: Completed NA study, sponsored by Rodrigo Ruano.
NCT03936322 is a NA study that has completed, run by Rodrigo Ruano. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03936322, a NA study, has completed, sponsored by Rodrigo Ruano.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Researchers are studying a new minimally invasive technique (fetoscopic repair) for repair of spina bifida (MMC) during the second trimester of pregnancy. Researchers are trying to determine if this less invasive surgical approach will have less risk to the mother and at the same time adequate closure of the fetal spina bifida defect.
Primary Outcome
Total number of maternal adverse events
Interventions
- DEVICE Minimally invasive fetoscopic repair of MMC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-05-07 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT03936322 record still lists
NCT03936322 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Minimally invasive fetoscopic repair of MMC is the first listed.
NCT03936322 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03936322 about?
NCT03936322 is a clinical study titled "Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study". Researchers are studying a new minimally invasive technique (fetoscopic repair) for repair of spina bifida (MMC) during the second trimester of pregnancy. Researchers are trying to determine if this less invasive surgical approach will have less risk to the mother and at the same time adequate closu...
What is the current status of trial NCT03936322?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2019-05-07. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT03936322?
The interventions under investigation include: Minimally invasive fetoscopic repair of MMC (DEVICE).
Who is sponsoring clinical trial NCT03936322?
This trial is sponsored by Rodrigo Ruano, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03936322's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI